How the story developed

Moderna Cancer Trial Success Is a Shot in the Arm for Trump

5 outlets 6 reports 31 hours Politics
ft.com2 newsweek.com arstechnica.com finance.yahoo.com marketwatch.com
19 August 2026
14:08 ft.com first
Moderna share price doubles on melanoma vaccine trial success
15:12 newsweek.com +1h
Moderna Cancer Trial Success Is a Shot in the Arm for Trump
16:33 ft.com +1h
Moderna’s cancer shot: exciting for investors, inconclusive for patients
18:53 arstechnica.com +2h
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
18:54 finance.yahoo.com
Moderna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Here's What That Means for Investors.
20 August 2026
21:01 marketwatch.com +26h
Moderna’s personalized mRNA shot could reshape the fight against skin cancer — but it may also be overhyped
Grouped automatically by shared headline terms across outlets. Each entry links to our translation; the original publisher is credited there.
News